In Alzheimer’s disease, the accumulation of amyloid β plaques triggers the activation of the NLRP3 inflammasome, resulting in increased production of IL-1β, which subsequently recruits immune cells and exacerbates neuronal damage [2, 63, 64]. Here, NLRP3 is linked to Alzheimer disease.